• Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Log in to your Inderes Free account to see all free content on this page.
Create account

Enzymatica

2.48 SEK-0.40 %10.7. klo 18.29
Less than 1K followers

ENZY

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
-0.40 %
-9.82 %
-19.74 %
+18.10 %
+30.53 %
-18.15 %
+3.15 %
-73.49 %
-56.59 %

Enzymatica is a life science company that develops and sells medical devices against infectious diseases. The products are based on barrier technology, which includes marine enzymes. The company's first product is ColdZyme® Mouth Spray, which can prevent colds and shorten the duration of the illness. The product has been launched in several markets and the strategy is to expand to more markets through partners. The head office is located in Lund.

Read more
Market cap
601.98M SEK
Turnover
86.59K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Press releases
3rd party
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
16.7.
2026

Interim report Q2'26

29.10.
2026

Interim report Q3'26

18.2.
2027

Annual report '26

Press release24.06.2026 klo 09.05

The evidence base for ColdZyme remains unchanged – PLOS ONE notice concerns the presentation of the Berlin II article, not the evidence base for ColdZyme

Enzymatica
Press release09.06.2026 klo 09.45

Enzymatica appoints Marketing and Sales Director to accelerate ColdZyme’s continued growth in the Nordics

Enzymatica
Regulatory press release07.05.2026 klo 17.05

Bulletin from annual general meeting of Enzymatica AB (publ) on 7 May 2026

Enzymatica

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Regulatory press release28.04.2026 klo 09.30

Enzymatica AB: Quarterly report Q1/2026 - Enzymatica strengthens international position through STADA agreement

Enzymatica
Regulatory press release14.04.2026 klo 11.00

Enzymatica AB: Enzymatica publishes annual report for 2025

Enzymatica
Regulatory press release31.03.2026 klo 15.00

Enzymatica AB: Enzymatica and STADA sign partnership agreement for Germany and Austria

Enzymatica
Regulatory press release31.03.2026 klo 11.45

Notice of Annual General Meeting 2026 in Enzymatica AB (publ)

Enzymatica
Regulatory press release18.02.2026 klo 09.30

Enzymatica AB: Year-end report 2025: New CEO takes the helm - initiates the next phase of Enzymatica's international expansion

Enzymatica
Press release11.12.2025 klo 13.00

Enzymatica AB: Enzymatica appoints Acting CFO during transition period

Enzymatica
Press release26.11.2025 klo 11.46

BioStock: Enzymatica enters partnership with the UK Sports Institute to strengthen elite athlete health

Enzymatica
Press release20.11.2025 klo 09.30

Enzymatica AB: Enzymatica enters partnership with the UK Sports Institute to support athlete health and performance

Enzymatica
Press release04.11.2025 klo 16.13

BioStock: Enzymatica’s CEO steps down after four years – summarizes a journey from science to commercialization

Enzymatica
Regulatory press release30.10.2025 klo 09.30

Enzymatica AB: Quarterly report Q3/2025: Strong development in Sweden and continued focus on international expansion

Enzymatica
Press release15.10.2025 klo 10.17

BioStock: Enzymatica launches new ColdZyme flavour

Enzymatica
Press release14.10.2025 klo 10.25

Enzymatica AB: ColdZyme launches a refreshing new flavour - Eucalyptus

Enzymatica
Regulatory press release13.10.2025 klo 11.00

Enzymatica AB: Enzymatica appoints Holger Lembrér as new CFO

Enzymatica
Press release01.10.2025 klo 14.00

Enzymatica AB: Enzymatica to Support Swedish Biathlon Federation as Official Supplier

Enzymatica
Regulatory press release22.08.2025 klo 14.50

Bulletin from the Extraordinary General Meeting of Enzymatica AB (publ) on 22 August 2025

Enzymatica
Regulatory press release12.08.2025 klo 09.00

Sana Alajmovic appointed new CEO of Enzymatica AB

Enzymatica
Regulatory press release06.08.2025 klo 09.30

Notice of Extraordinary General Meeting in Enzymatica AB (publ)

Enzymatica